Brief: Oncopeptides Q4 Operating Loss Narrows To SEK 81 Million
Feb 27 (Reuters) - Oncopeptides AB ONCO.ST :
* Q4 NET SALES SEK 5.3 MILLION VERSUS SEK 0.6 MILLION YEAR
AGO
* Q4 OPERATING LOSS SEK 81 MILLION VERSUS LOSS SEK 100.5
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN2H9q8z
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy